04/04/2025 6:44 AM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form 424B3 | |
04/03/2025 11:15 PM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form EFFECT | |
03/27/2025 4:05 PM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form POS AM | |
03/27/2025 4:07 PM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025 4:15 PM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/20/2025 6:31 AM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 7:30 AM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 7:30 AM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/02/2024 4:31 PM | Kim Hyung Heon (Reporting) MetaVia Inc. (Issuer) MetaVia Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2024 8:10 AM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2024 7:35 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MTVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MetaVia and its competitors with MarketBeat's FREE daily newsletter.
|
11/07/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 6:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 7:07 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 3:20 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 3:10 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form PRE 14A | |
07/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form EFFECT | |
07/24/2024 4:11 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 424B3 | |
07/18/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/16/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 10:11 AM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4/A | |
06/26/2024 8:15 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 3:15 PM | DONG-A ST CO., LTD (Filed by) NeuroBo Pharmaceuticals, Inc. (Subject) NeuroBo Pharmaceuticals, Inc. (Subject) MetaVia (Subject)
| Form SC 13D/A | |
06/25/2024 3:16 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 424B5 | |
06/25/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/24/2024 5:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer) Tursi James Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer) STRICKLAND D GORDON (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | Glickman Mark A (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | KOVEN ANDREW I (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | GROVES JASON L (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer) Salsbury Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 8:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 7:05 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Controversial opinion: Volume isn't enough. (Ad) Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if supply is just as high.
That’s why Tim Bohen created a new indicator designed to pinpoint stocks with high demand and low supply — the ideal setup for explosive moves. Tim Bohen’s new indicator reveals the perfect trade setup: high demand, low supply. |
04/30/2024 7:41 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form DEF 14A | |
04/30/2024 7:42 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form ARS | |
04/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form EFFECT | |
04/17/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:30 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |